Global Acne Drugs Market (2021 to 2026) - Featuring AbbVie, Almirall and Galderma Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Acne Drugs Market (2021-2026) by Acne Type, Therapeutic Class, Drug Type, Drug Formulation, Distribution Channel, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The global acne drugs market is estimated to be $5.4 billion in 2021 and is expected to reach $7.66 billion by 2026, growing at a CAGR of 7.25%.

The growing unhealthy lifestyle coupled with increasing interest in facial aesthetics amongst individuals is the primary factor estimated to drive the growth of the Global Acne Drugs Market. In addition, the increasing awareness of acne treatment via social media advertisement and the development of generic drugs is boosting the market growth. However, side effects associated with acne drugs and stringent government regulations associated with the development and manufacturing of the drugs are expected to hinder the market growth during the forecast period.

Conversely, increasing R & D of effective medications with lesser side effects coupled with high market potential in untapped emerging economies are expected to provide lucrative growth opportunities for the market growth.

The global acne drugs market is segmented further based on Acne Type, Therapeutic Class, Drug Type, Drug Formulation, Distribution Channel, and Geography.

Company Profiles

Some of the companies covered in this report are Almirall, Bausch Health Companies, Johnson & Johnson, Galderma, Mayne Pharma, Guthy-Renker. etc.

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Acne Drugs Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Market Dynamics

Drivers

• Increase in Prevalence of Acne
• Unhealthy Urban Lifestyle
• Rising Focus Facial Aesthetics

Restraints

• Side Effects Associated with Acne Medications
• Presence of Substitutes Acne Drug Treatment

Opportunities

• Growing Awareness of Combination Therapy and Natural Ingredients
• Opportunities In Emerging Economies
• Robust Acne Medications in Pipeline

Challenges

• Stringent Regulations for Acne Drug Approval Process

Companies Mentioned

• AbbVie
• Akorn
• Alembic Pharmaceuticals
• Almirall
• Bausch Health Companies
• Bayer HealthCare
• Cipher Pharmaceuticals
• Daiichi Sankyo
• Galderma
• Guthy-Renker
• Johnson & Johnson
• Mayne Pharma
• Nestle Skin Health
• Pfizer
• Reckitt Benckiser
• Roche
• Skinvisible Pharmaceuticals
• Stiefel (Glaxosmithkline)
• Sun Pharmaceutical
• Teva Pharmaceutical
• Valeant Pharmaceutical

For more information about this report visit https://www.researchandmarkets.com/r/mi15ll

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900